Ramping up

At first, everything seemed ideal. Alys was placed in a luxurious environment, where a medical team and nutritionists looked after her well-being. Her investors wanted to maximize their return: the healthier she was, the higher the value of her tokens.
Her story inspired thousands of people around the world. She became a star of the crypto sphere, accumulating millions in investments. Her model was touted as a solution to poverty, enabling individuals to harness their own biological potential.
But the first cracks appeared.

Pressure from investors

Soon, investors were clamoring for increased performance. They voted for “optimizations”: a stricter diet, intensive hours of sport, medical experiments aimed at prolonging the youthfulness of her cells.
Alys began to feel the effects of this pressure. She had less and less control over her body and her life. Her daily decisions, from sleep to personal relationships, had to be justified to a virtual committee of investors.
The excessive selling of tokens by speculators led to instabilities in her health. Cellular damage worsened, and Alys discovered to her horror that the price of her tokens fluctuated according to her pain and stress.